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Abstract 
Rationale: Recent evidence suggests that recreational cocaine use is on the increase, with the UK 
reporting one of the highest levels of use in the EU (EMCDDA, 2010). Nevertheless, very few studies 
have addressed the neuropsychological effects associated with non-dependent recreational cocaine use.  
Objectives: The current study aimed to assess whether recreational cocaine users show 
neuropsychological deficits on a battery of tests, previously shown to be sensitive to cocaine dependent 
and psychosis-prone individuals. Schizotypal traits were also measured.  
Methods: Recreational cocaine users (n=17) were compared with controls (n=24) on drug use patterns, 
the General Health Questionnaire (GHQ-12), the Brief Schizotypal Personality Questionnaire (SPQ-B) 
and four neuropsychological tasks: spatial working memory, Intra/extra dimensional set-shifting, the 
Stocking of Cambridge, and the Rapid Visual Processing.  
Results: Relative to controls, recreational cocaine users produced significantly more errors on the 
intra/extra dimensional set shift task and completed fewer stages; made significantly more 6 box stage 
errors on the spatial working memory task; and made significantly more errors and fewer hits, with 
overall poorer detection rates on the rapid visual processing task. Recreational cocaine users reported 
significantly higher scores on the cognitive-perceptual and disorganised thinking SPQ-B subscales and 
total SPQ-B scores compared to controls.   
Conclusions: Recreational cocaine users displayed impairments on tasks tapping sustained attention, 
attentional shifting and spatial memory and reported higher schizotypal trait expression.  These findings 
are consistent with the emerging literature suggesting subtle cognitive deficits, putatively reflecting 
underlying dopaminergic dysfunction, in non-dependent, recreational cocaine users. 
 
Keywords: recreational cocaine, neuropsychological, schizotypy, deficits, attention, working memory 
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Introduction 
 
Recreational cocaine use is on the increase and the UK has the highest levels of reported use in the EU 
(EMCDDA, 2010).  Last year the prevalence of cocaine use among young adults (aged 15-34 years) in 
the UK was 6.2%, well above the EU average of 2.3% (EMCDDA, 2010). Lifetime prevalence amongst 
16-59 year olds is estimated at 9.4%, even higher in young adults (15-34 years) at 14.9%; higher than 
other known recreational substances such as ecstasy (8.6% in 16-59 years and 13.8% in 15-34 years; 
EMCDDA, 2010). 
 
Cocaine is a dopaminergic stimulant, but long term chronic use has been associated with a number of 
neuropharmacological abnormalities.  These include a depletion, and reduced functioning of D2 
receptors in the orbitofrontal cortex, cingulate gyri and striatum (Volkow et al, 1993, 1997, 1999; 
Martinez et al, 2007, 2009), dysfunctions in frontal brain regions including orbitofrontal, lateral 
prefrontal and anterior cingulate cortex (Bolla et al, 2001, 2003, 2004), as well as anterior cingulate and 
cerebellum (Hester and Garava, 2004). A reduced uptake of l-dopa (the precursor to dopamine) has also 
been reported in abstinent cocaine users (Volkow et al, 1996).  Some recent evidence suggests that 
cocaine may even be a dopaminergic neurotoxin within the mid brain (Little et al 2009).  
 
The above implicated areas are commonly associated with the control of goal-directed behaviour; the 
anterior cingulate gyrus is heavily implicated in attentional function (Yamaski et al 2005) and response 
inhibition (Hester and Garavan, 2004), and the orbitofrontal cortex is associated with decision making 
(Bolla et al, 2003). That cocaine dependence and abuse has been frequently associated with 
neuropsychological and cognitive deficits (e.g. Bolla et al, 1999; Hester and Garavan, 2004; Verdejo-
Garcia and Perez-Garcia, 2007) is therefore not surprising. According to one meta-analysis assessing 
cognitive deficits in abstinent cocaine abusers, the largest effect sizes were found in attentional 
measures, with moderate effect sizes shown in visual and working memory and some aspects of 
executive functioning (Jovanovski et al, 2005). 
 
 
Nevertheless, whether recreational levels of drug use can also cause long-term reductions in 
dopaminergic functioning and subsequent neuropsychological effects has been relatively unexplored.  
Evidence to suggest that recreational, rather than chronic use of cocaine may be associated with altered 
dopaminergic functioning (particularly in the striatum) stems from a study assessing  spontaneous eye-
blink - a known clinical marker for dopaminergic functioning. Colzato et al (2008) demonstrated that 
recreational cocaine users (monthly intranasal consumption of 1-4 grams for a minimum of 2 years) 
displayed a significantly reduced eye-blink rate relative to non-cocaine users.  The amount of cocaine 
consumed, moreover, was negatively correlated with the degree of dopaminergic alteration (as indexed 
via reduced eye-blink rate).  Given these putative alterations in dopamingeric functioning associated 
with a recreational level of use, one might expect to see parallel alterations in cognitive performance. 
 
To date only a handful of studies have addressed the neuropsychological or cognitive effects associated 
with recreational or non-dependent cocaine use.   Rahman and Clarke (2005) demonstrated 
neurocognitive impairments in areas of attention and verbal recognition (but also  improvements in 
category fluency) in a sample of recreational cocaine users relative to non-drug using controls, with the 
duration and intensity of use correlating with some aspects of functioning.  Their cocaine users, 
however, predominantly used crack cocaine, a derivative of powdered cocaine which is not 
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representative of the majority of ‘recreational’ users (who tend to snort powdered cocaine).  Indeed, 
crack cocaine is commonly associated with a different pattern of usage (Chen and Anthony, 2004), 
abuse potential (Gossop et al, 1994) and behavioural differences (Gossop et al, 2006) and as such, may 
be associated with a different profile of cognitive impairment. 
  
In another study primarily aimed at assessing the cognitive effects of ecstasy (MDMA) use, Groth-
Marnat et al (2007) reported that a greater lifetime use of cocaine, rather than ecstasy, was associated 
with the severity of  decrement in general memory and delayed verbal memory.  More recently, Colzato 
and colleagues (2007, 2008, 2009a, 2009b) have reported a number of studies solely addressing 
recreational cocaine use. Recreational cocaine users were defined as those who did not meet the DSM-
IV criteria for abuse or dependence and had a monthly consumption of 1-4grams (often consumed in 
only a few sessions, so that peak use often equated to monthly use; Colzato et al, 2008).  They 
demonstrated a range of cognitive impairments amongst the recreational cocaine users (relative to non-
cocaine polydrug users) in areas of cognitive flexibility, response inhibition, inhibition of return (IOR) 
and visual attention, but not in working memory (Colzato et al, 2009a).  Deficits did not appear to be 
related to other drug use (e.g. ecstasy/MDMA, cannabis, alcohol and nicotine) and in some cases 
(inhibitory control for example) deficits were related to lifetime cocaine exposure (Colzato et al, 2007).  
Impairments were similar, but smaller in magnitude, to those observed in chronic users which are 
commonly attributed to dopaminergic malfunction (Bolla et al, 2001; Tomasi et al, 2010) suggesting that 
even recreational use of cocaine might begin to compromise dopaminergic pathways. 
 
Although there are many compelling arguments for cocaine-induced impairments in cognitive 
functioning via direct alteration of the dopamine system (e.g. Volkow et al, 1993; Volkow et al, 1997; 
Volkow et al, 1999; Martinez et al, 2007, 2009; Tomasi et al, 2010), as highlighted by Colzato et al 
(2009a) it is also possible that a number of pre-existing factors might account for the observed cognitive 
deficits either directly or via increasing the likelihood that certain individuals will use the drug.   Such 
vulnerability factors might include cognitive disturbance (Bechara, 2005), dopaminergic receptor 
dysfunction (Nader et al, 2006) or preexisting personality traits, such as impulsivity (Verdejo-Garcia et 
al, 2008) or schizotypy.    
 
Schizotypy has received little attention in the recreational drug use literature. It can be measured in both 
clinical and normal populations using psychometric measures such as the Schizotypal Personality 
Questionnaire (SPQ; Raine, 1991a) and the trait is generally considered to provide an index of  
psychosis-proneness (e.g. Chen et al, 1997; Tsakanikos and Reed, 2004; Berigda and Lenzenwger, 
2006).   Schizotypy scores are generally higher in adolescents and young adults (Raine, 1991; ages at 
which drug use is usually initiated) and among recreational drug users including current cannabis users 
(Skosnik et al, 2001; Schiffman et al, 2005; Fridberg et al 2011) and recreational ketamine users 
(Morgan et al, 2004). Whilst little attention has been given to assessing whether cocaine users also 
report higher schizotypy levels, cocaine use has been associated with aspects of schizotypy - psychosis 
and paranoia (e.g Cubells et al, 2005; Floyd et al, 2006; Kalaysariri et al, 2006).    Levels of schizotypy 
traits in general population samples have also been associated with cognitive performance including 
sustained attention (Bergida and Lenzenweger, 2006) and working memory (Schmidt-Hansen and 
Honey, 2009).  Given the above, it is likely that schizotypy may be a confounding personality trait when 
assessing potential cognitive effects associated with recreational cocaine use.  Thus, the current study 
aimed to assess whether recreational cocaine users show neuropsychological deficits on a battery of tests 
previously shown either to be sensitive to dopaminergic functioning and/or, to be impaired in dependent 
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cocaine users whilst controlling for schizotypy and other drug use.  Given the high rate of polydrug use 
among recreational users (e.g. Kelly and Parsons, 2008; Grov et al, 2009), isolating the effects of 
cocaine on cognitive functioning is a difficult task.  Here we will minimize polydrug effects in the 
cocaine group by not excluding participants who reported other drug use (with the exception of cocaine).    
 
 
 
 
Methodology 
 
Participants 
 
Cocaine users 
 
Seventeen recreational cocaine users were recruited (5 male, 12 female).  Recreational cocaine use was 
defined as using intranasal cocaine within the last year, but on no more than 10 occasions within the last 
month.  Polydrug use was also reported within this group (see table 2).  The mean age of the group was 
28.6+5.3 years.  59% (n=10) classified themselves as white, 35% (n=6) as black, and 6% (n=1) mixed 
ethnicity. 18% (n=3) of participants were educated to GCSE level only, 29% (n=5) to A-level, 12% (n=2) 
to NVQ level, 29% (n=5) to degree level and 12% (n=2) to postgraduate level 
 
Controls 
Twenty-four participants (8 male, 16 female) who reported no cocaine use within the last year were 
recruited as a control group.  38%  (n=9) reported use of other recreational drugs within the last month (see 
table 2).  The mean age of the group was 25.6+4.5 years.  50% (n=12) classified themselves as white, 13% 
(n=3) as black, 17% (n=4) as mixed and 21% (n=5) as asian.   4% (n=1) of participants were educated to 
GCSE level only, 38% (n=9) to A-level, 4% (n=1) to NVQ level, 33% (n=8) to degree level and 13% 
(n=3) to postgraduate level.  A further 8% (n=2) indicated ‘other’. 
  
All participants were recruited either through advertisements placed around the University of East 
London (UEL) grounds or via the snowball technique (Solowji et al, 1992).  Self-reported exclusion 
criteria for both groups were 1) current use of psychiatric medication, 2) epilepsy, 3) current treatment for 
any psychological problem or substance/alcohol dependency, 4) sustained head injury, 5) current 
pregnancy and  6) drug use within 24 hours prior to testing.  All participants gave written informed 
consent and the study was approved by the UEL Ethics Committee. 
 
Questionnaire assessment: 
 
All participants provided demographic details, and information regarding personal and family 
psychiatric histories.  They also completed the UEL drug use questionnaire (Parrott, Sisk and Turner, 
2000) to assess drug use within the last month with additional questions pertaining to patterns of cocaine 
use, subjective effects associated with their cocaine use and a measure of dependence.  Dependence was 
measured using the Severity of Dependence Scale (SDS; Gossop et al, 1995).  This is a 5-item 
questionnaire; each item is rated on a 4-point scale; ‘never’, ‘sometimes’, ‘often’ and ‘nearly always’, 
with scores awarded from 0-3 respectively. Total scores therefore ranged from 0-15, with a higher score 
reflecting a higher level of dependence. 
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The Brief Schizotypal Personality Questionnaire (SPQ-B: Raine, 1991b) was used to assess levels of 
schizotypy traits.  This 22 item questionnaire uses a yes/no response with scores awarded for every ‘yes’ 
response.  As well as a total score, the scale comprises 3 subscales; cognitive perceptual, interpersonal 
and disorganized schizotypy.  A higher score indicates higher schizotypal proneness. 
 
The General Health Questionnaire (GHQ-12; Goldberg and Williams, 1988) was used for a general 
measure of psychological health.  The scale consists of 12 items utilizing a four point Likert scale; ‘less 
than usual’, ‘no more than usual’, ‘rather more than usual’ and ‘much more than usual’, with scores 
awarded from 0-3 respectively.  Total scores range from 0 to 36; with a higher score reflecting poorer 
psychological health. 
 
Neuropsychological assessment: 
 
All tasks were administered from the CANTAB (Cambridge Cognition, CeNeS Ltd. Cambridge UK) via 
a portable computer with a Datalux touch-sensitive screen.  All participants were given verbal as well as 
written instructions (via the CANTAB) on how to complete each task.  The tasks were administered in 
the following order: 
 
Spatial working memory task (SWM) 
 
The SWM task tests the ability to retain spatial information and to manipulate remembered items in 
working memory.    Participants are required to find  a number of blue tokens (dependent on the trial) in 
one of several boxes (a search) and move that token to a column on the right side of the screen, whilst 
not returning to a box which previously contained that  token.  Participants have to find all the blue 
tokens to fill the column.  The number of boxes increases over the test period, until there are 8 boxes to 
search in.  The colour and position of the boxes change over consecutive trials.  On each trial, returning 
to an empty box which has already contained a blue token constitutes an error.  Errors are broken down 
into the number of between errors (times the participant revisits a box in which a token has previously 
been found) and the number of within errors (number of times a participant revisits a box already found 
to be empty during the same search) for total trials and 4-, 6- and 8-box trials; as well as total errors; and 
a strategy score (the number of times a new search begins with the same box). 
 
Intra-Extra Dimensional Set Shift (IED) 
The IED is an executive functioning task, which tests rule acquisition and reversal. It features visual 
discrimination, attentional set formation and maintenance, shifting and flexibility of attention.  Simple 
stimuli are made up of one of two artificial dimensions; colour-filled shapes and white lines.  Compound 
stimuli comprise white lines overlying colour-filled shapes.  Participants are initially presented with two 
simple coloured shapes and must learn which one is correct by touching it.  Once criterion is reached the 
contingencies are reversed, i.e. the incorrect stimulus becomes the correct stimulus.  A second 
dimension is then introduced, initially lying adjacent to, and then overlapping, the first dimension.  The 
contingencies remain the same as at the end of the simple discrimination.  Again once criterion has been 
reached with the overlapping compound stimulus, the contingencies are again reversed.  When the 
participants have learnt this compound discrimination, new compound stimuli are presented and 
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participants are required to learn which of the new dimensions are correct (the intra-dimensional shift).  
Participants are then required to shift attention to the previously irrelevant dimension and learn which of 
the two exemplars in this dimension is now correct (the extra-dimensional shift).  Criterion for each 
stage is 6 consecutive correct responses and, if at any stage the criterion isn’t reached, the test is 
terminated after 50 trials.  The following performance indices for this task were recorded: the number of 
errors made on stages successfully completed (completed stage errors), the number of trials on all 
successfully completed stages (completed stage trials), the number of errors made prior to the extra-
dimensional shift (pre-ED errors), number of stages completed (out of a total 9), total errors adjusted (a 
measure of performance efficiency, adjusted to account for each stage not completed due to failure), and 
number of trials completed on all attempted stages adjusting for stage not attempted due to failure at an 
earlier stage (total trials adjusted). 
The Stockings of Cambridge (SOC) 
The SOC is a measure of spatial planning.  Participants are shown two displays consisting of three 
coloured balls which appear to be stacked on top of one another.  The participant must move the balls in 
the lower display, by touching the required ball and moving it to the desired location, to mimic the upper 
display.  Participants’ planning abilities are measured by a) the time, and b) the number of moves 
required to complete the pattern.  As the test continues the number of moves required to match the upper 
display increases, such that planning problems consist of 2, 3, 4 and 5 moves.   The difference in time 
taken to complete each problem is indicative of the additional time taken to plan the solution.  If the 
participant takes more than double the required number of moves to complete the solution, the trial is 
terminated.  The test is ended in the event of three consecutive terminations.   Outcome measures for 
each of the 2-, 3-, 4- and 5- move problems are: a) the time taken to plan the solution (mean initial 
thinking time), b) the number of moves required to solve the problem, c) the speed of movement after 
the initial move has been made (subsequent thinking time) and d) the number of occasions the trial has 
been successfully completed in the minimum number of possible moves (problems solved in minimum 
moves). 
 
Rapid visual processing (RVP) 
 
The RVP is a measure of sustained attention.  Participants are required to detect consecutive odd or even 
sequences of digits (e.g. 2-4-6, 5-7-9), presented one digit at a time in a white box in the centre of the 
screen.  Digits are presented in pseudo-random order at a rate of 100 digits per minute, with 16 target 
sequences occurring every 2 minutes.  The first 4 minutes of the test constitutes a ‘warm up’ and the 
final 3 minutes are scored.  The number of correct responses is recorded (total hits), along with the 
number of total misses (occasions where there has been a failure to respond to a target sequence), the 
mean response latency and a measure of how good the participant is at detecting target sequences (RVP 
A’); using the probability of both a hit and false alarm – thus a measure of sensitivity to errors regardless 
of error tendency (ranging from 0-1; bad to good). 
 
Data analysis 
 
All data was processed and analysed using the Statistical Package for Social Science (SPSS) version 18 
in Windows Vista.  Chi-square analyses were conducted on all categorical demographic and drug use 
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data.  The remaining demographic and drug use data were analysed using independent t-tests; where 
Levene’s homogeneity of variance was significant ‘equal variances not assumed’ values are presented.  
ANOVAs were preformed on all neuropsychological test data. Observed power and effect sizes are also 
reported. There were missing data for 2 cocaine users and 3 control participants on the intra-extra 
dimensional shift and rapid visual processing tasks, therefore group analyses were conducted on the 
smaller sample of 15 cocaine users and 21 controls for these tests only.  Further ANCOVAs, with age 
and total schizotypy scores were used as separate covariates on test data where significant group 
differences were found.  Whilst cannabis and benzodiazepine (BDZ) use differed significantly between 
groups, data violated the assumption for use as a covariate because a) use was very low for BDZ use, 
and b) data was subjective (Tabachnick and Fidell 2007).    Correlation analyses were conducted on 
measures of cocaine use and schizotypy scores and task data.    The threshold for statistical significance 
for all main effects and correlations was set at the more stringent level of p<0.01 given the multiple 
comparisons. 
 
 
Results 
 
Participant and drug use data 
 
Tables 1 and 2 present a summary of participant characteristics and drug use for the two groups. There 
were no significant differences in frequencies between groups for gender, ethnicity and education 
[chi2(1)= 0.71, p=0.79], [chi2 (5)=4.30, p=0.51] and [chi2(3)=6.99, p=0.07] respectively.  There was no 
significant group difference in age,  [t(39)=2.15, p=0.037].   
 
There were no significant group differences between cocaine users and non-cocaine users on all other 
drug use except duration of cannabis use (in years) [t(37)=-0.52, p<0.001]; cocaine users reported using 
cannabis for significantly more years.   
 
There were no significant group differences on psychological health as measured by the GHQ, 
[t(39)=0.30, p=0.77].  There were significant group differences in schizotypy levels with cocaine users 
reporting significantly higher total scores [t(39)=3.28, p=0.002] and higher scores on the cognitive 
perceptual and disorganised subscales [t(39)=2.64, p=0.012], [t(39)=4.06, p<0.001] respectively.  There 
were no significant correlations between measures of cocaine use and total schizotypy scores. 
 
Table 3 summarises the pattern of cocaine use amongst the recreational cocaine group.  The measure of 
dependence to cocaine indicated a low dependence level (mean = 2.59).   
 
 
Neuropsychological data 
 
Table 4 summarises the task data from all four CANTAB tasks. 
 
Spatial Working Memory (SWM) 
 
Relative to controls, recreational cocaine users made more total between errors, and more between errors 
at each box stage (4, 6 and 8) of the spatial working memory task (see table 3) indicating more visits to 
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boxes previously revealed to hold targets .  This difference was statistically significant only at the 6 box 
stage [F(1,39) = 9.08, p=0.005] and remained significant after covarying for both age and total 
schizotypy (p<0.05).  
 
No significant correlations were found between patterns of cocaine use and SWM performance on any 
of the indices. 
 
Intra/extra dimensional shift set (IED) 
 
Recreational cocaine users were significantly less efficient at completing the IED task, making more 
errors in the extra-dimensional stage of the task (EDS errors; F(1,34)= 12.32, p=0.001) and completed 
significantly fewer  stages within the task [F(1,34)=7.57, p=0.009 ] relative to controls.   All group 
differences remained statistically significant after covarying for both age and schziotypy (p<0.05)..  
Average cocaine use was also shown to significantly correlate with IED on pre-extra dimensional errors 
[r=0.64, p=0.01]. 
 
 
Stockings of Cambridge (SOC) 
 
As can be seen from table 3, recreational cocaine users took longer  to plan the solution (initial thinking 
time) and subsequently execute the task (subsequent thinking time) on problems consisting of 2  and 3 
moves, however they were quicker for problems consisting of 4 and 5 moves relative to non-users .  
However, these differences were not statistically significant.   Amount of cocaine use in the last month 
and year, correlated negatively with the mean initial thinking time on 3-move problems [r=-0.64, p<0.01 
and [r=-0.62, p<0.01 respectively].   
 
 
Rapid Visual Processing (RVP) 
 
Relative to controls, recreational cocaine users made significantly fewer hits [F(1,39)=12.73, 
p=0.001]and more misses [F(1,39)=19.34, p<0.001] thus demonstrating a significantly poorer 
performance at detecting target sequences [F(1,39)=21.67, p<0.001].  With the exception of mean 
latency, these differences remained significant after covarying for both age and schizotypy (p<0.01).   
No significant correlations were found between RVP performance indices and measures of cocaine use. 
 
 
Discussion 
 
Relative to controls, the recreational cocaine users in this sample displayed impairments on a number of 
tasks tapping executive functioning: spatial working memory, sustained attention and attentional shifting 
but were unimpaired on spatial planning.  
 
In relation to spatial working memory, cocaine users made more between errors on the 6-box trial. That 
is, they revisited boxes in which they had already located a target, significantly more times than non-
cocaine users indicating an inability to monitor and maintain the memory of previously located targets. 
It is interesting to note that there were no significant differences on the same trial for within errors 
Published in Psychopharmacology  
 
(number of times a participant revisits a box already found to be empty during the same search).  The 
literature on working memory and cocaine use is inconsistent.   In recreational cocaine users Colzato et 
al (2009a) failed to show any significant differences in the maintenance of information in working 
memory (as measured by the digit span, mental counters task and the N-Back task; mainly non-spatial 
tasks in nature) relative to controls, despite showing impairments on tasks assessing cognitive flexibility 
(WCST and the Dots triangles task; mainly spatial tasks).   Pace-Schott et al (2008) conversely, found 
impaired attention and delayed verbal recognition memory in abstinent cocaine abusers, whilst working 
memory was unaffected.  In Jovanoski et al’s (2005) meta- analysis assessing cognitive function in 
abstinence cocaine abusers, only moderate effect sizes were found on aspects of working memory.  This 
is mirrored in the current study which demonstrated only small effect sizes (<2; Cohen, 1988) on those 
aspects which were significant.   The fact that a significant effect was found on the 6-box trial but not 
the 4- and 8-box is difficult to explain but findings on these trials (and indeed on other task indices) 
were in the same direction; indicating recreational cocaine users were showing poorer performance on 
most measures on this task; perhaps given greater power such significant findings in recreational cocaine 
users may be evident.   
 
Recreational cocaine users also showed impairments on the intra/extra dimensional shift task (IED), 
successfully completing fewer stages and making more total errors compared to controls. Errors were 
made specifically during the extra-dimensional shift stage.  This pattern of findings suggests 
impairments in rule acquisition and reversal, as well as visual discrimination, attentional set formation 
and maintenance and flexibility of attention.  There is also some evidence to suggest that these deficits 
relate to the amount of cocaine use, with greater average amounts correlating significantly with errors on 
this task.  Again, these impairments are in accord with the findings reported by Colzato and colleagues 
(2007, 2008, 2009a, 2009b), who have consistently shown that recreational cocaine users display 
deficits in areas of cognitive flexibility, response inhibition, (IOR) and visual attention. 
 
The lack of significant group differences on the Stockings of Cambridge (SOC) task, tapping spatial 
planning is inconsistent with studies in chronic and dependent cocaine users, where evidence has shown 
motor abilities and planning to be impaired (e.g. Hoff et al, 1996; Bolla et al, 1999).  These findings 
suggest that this area of cognitive functioning may only be affected by chronic, dependent cocaine use.  
Nevertheless, given that this is the first study to specifically address spatial planning within recreational 
cocaine users, this remains speculative  
 
Recreational cocaine users demonstrated deficits in sustained attention, indicated by significantly more 
incorrect hits and misses on the Rapid Visual Processing task (RVP) than controls, and a poorer score on 
the RVP A’. Thus, cocaine users were significantly poorer at detecting target sequences relative to 
controls.   This particular sustained attention task is sensitive to dysfunction in the parietal and frontal 
lobe regions of the brain (e.g. Lawrence et al, 2003), areas also shown to be deficient in dopaminergic 
activity in chronic cocaine users (e.g. Volkow et al, 1993, 1997, 1999; Martinez et al, 2007, 2009).  
Attention itself is one cognitive domain which has consistently been shown to be impaired in chronic 
abstinent cocaine abusers; showing large effects sizes (Jovanovski et al, 2005). The existing evidence, 
although limited also suggests that attention is compromised in recreational cocaine users (Rahman and 
Clarke, 2005; Colzato and Hommel, 2009; Colzato et al, 2009b) and is not accounted for by other 
recreational drug use such as MDMA and cannabis (Colzato et al, 2009b).  Interestingly, the effects of 
recreational cocaine use on sustained attention in the current study were not associated with amount and 
duration of use.  This parallels Colzato and Hommel’s finding (2009), in users with similar patterns of 
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cocaine use; the magnitude of the inhibition of return effect (which involves attentional focus) was not 
proportional to cocaine consumption.   
 
As a group, recreational cocaine users reported higher schziotypal trait expression than controls; on the 
total score, and the ‘cognitive perceptual’ and ‘disorganised schizotypy’ sub-scales.   Although previous 
research has shown a link between other recreational drug use and schizotypy (e.g. Fridberg et al, 2011; 
Morgan et al, 2004), this is the first time higher levels of schizotypy have been reported in recreational 
cocaine users. That there were no significant correlations between measures of cocaine use and 
schizotypy scores implies that this is a constitutional trait associated with cocaine consumption rather 
than an effect of cocaine use.  Indeed this has also been shown within cannabis users; Schiffman et al, 
(2005) reported that schizotypy proceeded, but was not causally related to, cannabis use. 
 
It is possible that the higher levels of schizotypy in our cocaine users, rather than cocaine use per se, 
could independently result in the neuropsychological deficits evidenced in this group.  Prior evidence 
suggests that schizotypy in the normal population is associated with impaired motor control and 
cognitive function (e.g. Lezenweger and Maher, 2002) particularly sustained attention (Bergida and 
Lenzenweger, 2006), working memory (Schmidt-Hansen and Honey, 2009), spatial working memory 
(Park et al, 1995) and inhibitory functioning (e.g. Migo et al, 2006; Taskanikos and Reed, 2004).   
Nevertheless, given that schizotypy itself did not emerge as a significant covariate in the analyses 
conducted here, lends weight to the hypothesis that recreational cocaine use itself affects 
neuropsychological performance in the absence of schizotypal traits. 
 
The recreational cocaine users in this sample were using, on average, once a month and just under 2 
grams on each occasion, which equates to their self-reported amounts of money spent on cocaine per 
occasion (one gram of cocaine on average costs £40; DrugScope, 2009).   This level of usage is similar 
to that reported in other studies assessing recreational cocaine users (Colzato and colleagues, 2007, 
2008, 2009a, 2009b).  One advantage of the current study over previous studies assessing recreational 
cocaine users is the utilisation of a brief screening measure for psychological dependence to cocaine.  
Scores on this measure indicated that participants were not dependent on cocaine.   A common problem 
in recreational drug research is polydrug use (the use of more than one drug); isolating the effects of 
cocaine use (or any other single drug) on cognitive functioning therefore, is a challenge.  In the current 
study, minimal other drug use was reported by both controls and cocaine users, with the exception of 
cannabis.  Recreational cocaine users reported using cannabis for a longer duration, but their current 
monthly cannabis use was similar to controls. Thus it is unlikely that current cannabis use can account 
for the deficits seen in recreational cocaine users particularly given that cannabis is not know to be a 
long-term neurotoxin. 
 
 
 
The current study lends support to the notion that recreational cocaine use results in subtle but 
significant neuropsychological deficits in areas of attentional functioning and spatial working memory.  
These impairments do not appear to be due to other drug use and may not necessarily be dose related 
given the lack of significant correlations between levels of cocaine use and neuropsychological 
performance. Given that recreational cocaine use has previously been associated with altered 
dopaminergic functioning using the eye-blink marker (Colzato et al, 2008), one might tentatively 
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conclude that recreational cocaine use is sufficient in hampering dopamine-mediated cognitive 
functions. 
 
There are however, a number of other possible explanations for these deficits which need to be 
considered including amotivation in the cocaine users and ischemic strokes which have been shown to 
be associated with cocaine use (Westover, McBride & Haley, 2007); both issues could potentially 
account independently for the neuropsychological impairments shown in these recreational cocaine 
users.  In addition, the participants of this study reported high weekly alcohol consumption 
(approximately 18 units per week). Whilst groups didn’t differ on alcohol consumption, the co-
administration of alcohol and cocaine has been shown to produce cocaethylene (Farre et al, 1993), a 
psychoactive metabolite with toxic effects similar to cocaine (McCance et al 1995).  The 
neuropsychological impairments shown in the cocaine users could therefore be a result of cocaethylene 
or indeed a combination of both psychoactive substances. 
 
The current study relied on self-report data of current and past drug use and there was no objective 
confirmation (i.e. drug screen) of drug abstinence prior to assessment.  However, based on reported 
patterns of recent cocaine use (on average recent use was over 1 week prior to assessment), it is likely 
that participants were abstinent from the drug.  Furthermore, self report and objective indices of drug use 
in previous studies have shown strong associations, indicating self-report drug use to be reliable (e.g. 
Glintborg et al, 2008; Basurto et al, 2009).  Despite the reliability of self-report data there still remains 
the issue concerning the purity of cocaine that has been consumed in these users.  Within the UK (and 
most of Europe) the purity of cocaine has been in decline, with purity levels down to 20.3% in 2009 
(EMCDDA, 2011).  Cocaine is often ‘cut’ with other substances such as lidocaine and caffeine 
(EMCDDA, 2010) which could have partially contributed to the neuropsychological effects observed in 
the cocaine users.  
 
There are several other preexisting factors which might also account for the group differences observed 
here including dopaminergic vulnerability (Nadar et al, 2006), inhibitory control,  impulsivity (Bechara, 
2005; Verdejo-Garcia et al, 2008) and IQ. Future studies thus need to control for such pre-existing 
factors through statistical means or ideally through the use of a longitudinal studies.   A limitation of the 
current study worth noting is that there was no measure of pre-morbid IQ, therefore there may be pre-
existing group differences in IQ.  However given that the two groups did not differ on level of 
educational achievement indicates that group differences in performance were not due to lower IQ in the 
cocaine group.   
 
The relative low power in this study is also worth noting (see table 4).  Whilst there was insufficient 
power to detect some differences between cocaine users and controls, others were low (<80%) which 
may account for the lack of ability to detect further subtle differences between the groups.  Effect sizes 
here are also very small (<0.03), with the exception of some of the RVP indices.  Thus whilst there are 
significant differences between controls and recreational cocaine users on various indices of cognitive 
functioning (with sufficient power to detect them), clinically these deficits may not be immediately 
apparent, and more importantly, may not manifest themselves to the extent that they impact on a 
recreational cocaine user’s everyday life.  It would be of interest to assess the impact of these cognitive 
deficits on recreational cocaine users’ everyday functioning. 
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To conclude, relative to non-users, recreational cocaine users in this study displayed poorer performance 
on aspects of sustained attention, flexibility of attention, spatial working memory and rule acquisition 
and reversal (executive functioning) whilst spatial planning remained intact.  These impairments, 
moreover, did not appear to be mediated by other drug use or levels of schizotypy.  This study has also 
demonstrated, for the first time, elevated levels of schizotypy in a sample of recreational cocaine users.   
These findings are consistent with the emerging literature suggesting subtle cognitive deficits, putatively 
reflecting underlying dopaminergic dysfunction, in non-dependent, recreational cocaine users.    
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Table 1:  Mean (SD) for participant characteristics, GHQ-12 and SPQ-B measures in recreational 
cocaine users and controls 
 Recreational Cocaine 
Users 
 
Controls 
 
N 17 24 
Age  28.59 (5.27) 25.29 (4.50) 
Gender (M/F) 5/12 8/16 
GHQ 15.06 (8.00) 14.29 (8.24) 
SPQ-B Total 9.29 (4.06)*** 4.79 (4.50) 
Cognitive Perceptual 3.35 (1.93)*** 1.71 (1.99) 
Interpersonal 2.88 (2.20) 2.88 (2.20) 
Disorganised 3.06 (1.25)** 1.17 (1.61) 
**p<0.001; ***p<0.01 
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Table 2:  Drug use: number reporting use and mean (SD) times per month consumed (unless otherwise 
stated) in recreational cocaine users and controls. 
 
 Recreational 
Cocaine Users 
 
 Controls 
 
 
 Mean (SD) N Mean (SD) N 
Tobacco (cigarettes per day) 7.71 (7.33) 13 3.58 (6.01) 8 
Alcohol (units per week) 18.81 (15.31) 16 17.58 (32.08) 19 
Cannabis use (occasions per 
month) 21.44 (29.87) 15 21.67 (81.09) 9 
Cannabis: length of use (years) 9.93 (5.76)** 15a 2.63 (4.76) 8 
Cannabis: days since used 26.29 (87.62) 17 65.0 (297.36) 12 
Ecstasy/MDMA 0.53 (1.07) 5 0.17 (0.64) 2 
Amphetamine 0.06 (0.24) 1 0.04 (0.20) 1 
Mushrooms 0.12 (0.49) 1 - 0 
Amyl-nitrate 0.059 (0.24) 1 - 0 
Ketamine 0.12 (0.33) 2 - 0 
Benzodiazepines 0.76 (1.09) 7 0.08 (0.28) 2 
 
**p<0.001;  
a 2 missing data 
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Table 3:  Self-reported Patterns of Cocaine use for the Recreational Cocaine Users 
 
 Mean (SD) Range 
Age of first use (years) 20.82 (3.54) 17-27 
Duration since last used (weeks) 3.00 (2.68) 0-9 
No. occasions used  in last month 2.35 (2.23) 0-7 
No. occasions used in last year 20.18 (19.08) 0-70 
Lifetime consumption (no. of occasions) 264.57 (437.55) 3-1500 
Average use (grams) on each occasion 1.90 (1.07) 0.25-4 
Amount spent  (£) on each occasion 58.82 (45.23) 0-150 
Severity of Dependence Mean Score 2.59 (3.30) 0-13 
   
Frequency of use: %  
Weekly 17.6  
Monthly 52.9  
Every 3 months 11.8  
Yearly 17.6  
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Table 4:  Mean (SD) scores for each CANTAB task 
 Recreational Cocaine 
Users 
Controls P Effect 
size 
Observed 
power 
Spatial Working Memory       
Between errors 28.18 (18.71) 18.38 (18.62) 0.11 0.07 0.37 
4 boxes 1.41 (2.00) 0.67 (1.31) 0.16 0.05 0.30 
6 boxes 9.71 (6.40) 4.00 (5.67) 0.005 0.19 0.84 
8 boxes 17.06 (12.40) 12.04 (12.96) 0.22 0.04 0.23 
Strategy 33.76 (4.10) 30.50 (8.04) 0.13 0.06 0.32 
Total errors 31.24 (20.76) 18.75 (19.14) 0.05 0.09 0.50 
Within errors 0.82 (2.43) 0.83 (1.97) 0.99 >0.001 0.05 
4 boxes 0.06 (0.24) 0.04 (0.20) 0.81 0.002 0.06 
6 boxes 0.35 (1.22) 0.08 (0.28) 0.30 0.03 0.18 
8 boxes 0.41 (1.06) 0.75 (1.98) 0.53 0.10 0.10 
IED       
Completed stage errors 12.60 (9.59) 15.52 (16.74) 0.55 0.01 0.09 
Complete stage trials 69.00 (21.03) 70.62 (26.60) 0.85 0.01 0.05 
EDS errors 14.93 (9.61) 5.24 (6.99) 0.001 0.27 0.93 
Pre  ED errors 5.20 (3.03) 5.33 (2.69) 0.89 0.001 0.05 
Stages Completed 8.20 (0.94) 8.86 (0.48) 0.01 0.18 0.76 
Total errors1 32.67 (19.32) 17.86 (18.78) 0.03 0.14 0.61 
Total trials1 109.00 (34.43) 101.86 (108.37) 0.81 0.002 0.06 
SOC      
Mean initial thinking time       
2 moves 1598.89 (1916.64) 849.83 (650.29) 0.08 0.08 0.41 
3 moves 2151.56 (1694.34) 1671.13 (1014.03) 0.26 0.03 0.20 
4 moves 2595.60 (1996.68) 3143.44 (3853.12) 0.60 0.007 0.08 
5 moves 2771.59 (2508.36) 3657.41 (3297.79) 0.36 0.02 0.15 
Mean moves       
2 moves 2.24 (0.44) 2.06 (0.22) 0.11 0.07 0.07 
3 moves 3.21 (0.36) 3.29 (0.66) 0.63 0.06 0.08 
4 moves 5.59 (1.26) 5.58 (0.93) 0.99 <0.001 0.05 
5 moves 6.96 (1.26) 6.53 (2.06) 0.46 0.01 0.11 
Mean subsequent thinking time 
2 moves 165.97 (356.00) 149.85 (360.77) 0.89 0.001 0.05 
3 moves 156.49 (503.43) 88.81 (229.47) 0.57 0.01 0.08 
4 moves 445.55 (629.68) 504.57 (818.96) 0.81 0.002 0.06 
5 moves 220.46 (180.68) 382.01 (621.30) 0.31 0.03 0.17 
Problems solved in minimum 
moves 
7.76 (1.64) 8.21 (2.17) 0.48 0.01 0.11 
RVP      
RVP A’ 0.89 (0.04) 0.95 (0.04) <0.001 0.36 0.995 
RVP Mean latency 474.55 (90.56) 396.80 (114.35) 0.03 0.12 0.62 
Total hits 15.41 (4.40) 20.71 (4.87) 0.001 0.25 0.94 
Total misses 11.59 (4.40) 5.74 (4.05) <0.001 0.33 0.99 
1adjusted indices – adjusted to account for failed stage attempts  
